首页> 外文期刊>British Journal of Radiology >Effective dose: a flawed concept that could and should be replaced.
【24h】

Effective dose: a flawed concept that could and should be replaced.

机译:有效剂量:一个有缺陷的概念,可以并且应该被取代。

获取原文
获取原文并翻译 | 示例
           

摘要

The effective dose is designed to provide a single number proportional to the radiobiological "detriment" from a particular, often inhomogeneous, radiation exposure, with detriment representing a balance between carcinogenesis, life shortening and hereditary effects. It is commonly used to allow a comparison of the risks associated with different spatial dose distributions produced by different imaging techniques. The effective dose represents questionable science: two of the most important reasons for this are that the tissue-specific weighting factors used to calculate effective dose are a subjective mix of different endpoints, and that the marked and differing age dependencies for different endpoints are not taken into account. Importantly, the effective dose is prone to misuse, with widespread confusion between effective dose, equivalent dose and absorbed dose. It is suggested here that effective dose could and should be replaced by a new quantity that does not have these problems. An appropriate new quantity could be "effective risk", which, like effective dose, is a weighted sum of equivalent doses to different tissues; unlike effective dose, where the tissue-dependent weighting factors are a set of subjective committee-defined numbers, the weighting factors for effective risk would simply be evaluated tissue-specific lifetime cancer risks per unit equivalent dose. The resulting quantity would perform the same comparative role as effective dose; it would have the potential to be age- and, if desired, gender-specific, just as easy to estimate, less prone to misuse, more directly interpretable, and based on more defensible science.
机译:设计有效剂量以提供与特定(通常是不均匀的)放射线照射的放射生物学“损害”成比例的单个数字,该损害表示致癌作用,寿命缩短和遗传效应之间的平衡。它通常用于比较与不同成像技术产生的不同空间剂量分布相关的风险。有效剂量代表了可疑的科学:这两个最重要的原因是,用于计算有效剂量的组织特异性加权因子是不同终点的主观混合,并且未采用针对不同终点的明显且不同的年龄依赖性考虑在内。重要的是,有效剂量易于滥用,有效剂量,等效剂量和吸收剂量之间存在广泛的混淆。在此建议有效剂量可以并且应该由不存在这些问题的新剂量代替。适当的新数量可以是“有效风险”,与有效剂量一样,它是对不同组织的等效剂量的加权总和。与有效剂量不同,在有效剂量中,取决于组织的加权因子是一组主观委员会定义的数字,有效风险的加权因子可以简单地通过每单位当量剂量评估组织特定的终生癌症风险。所得数量将起到与有效剂量相同的比较作用;它有可能具有年龄特征,如果需要,还可以根据性别而定,就像容易估计,不容易被滥用,更易于直接解释,基于更可辩护的科学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号